Cite
HARVARD Citation
Schoenfeld, P. et al. (2014). Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials. Alimentary pharmacology & therapeutics. 39 (10), pp. 1161-1168. [Online].